Menlo Therapeutics Inc. (MNLO) Prices 7M Share IPO at $17/Sh

Menlo Therapeutics Inc. (NASDAQ: MNLO) today announced the pricing of the Company’s initial public offering of 7,000,000 shares of common stock at a public offering price of $17.00 per share, before underwriting discounts. All of the shares of common stock are being offered by Menlo. The Company has also granted the underwriters a 30-day option to purchase from the Company an additional 1,050,000 shares of common stock at the initial public offering price, less the underwriting discount. Menlo’s common stock has been approved for listing on The Nasdaq Global Select Market and is expected to begin trading under the ticker symbol “MNLO” on January 25, 2018. The offering is expected to close on January 29, 2018, subject to customary closing conditions.

Jefferies LLC, Piper Jaffray & Co. and Guggenheim Securities, LLC are acting as joint book running managers for the proposed offering. JMP Securities is acting as the lead manager for this offering.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Macquarie Upgrades Broadcom Limited (AVGO) to Outperform
• MediaAlpha names new CFO and raises Q3 2026 guidance